Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

Published Date: 08 Dec 2023

Treatment-sensitive patients may benefit most from ongoing care, according to an expert.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

2.

Stevia leaf extract has potential as anticancer treatment, researchers find

3.

Combination therapy improves outcomes for advanced triple-negative breast cancer

4.

An understudied type of breast cancer poses a lurking threat

5.

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot